Striatin 3 upregulation resulted in hyperactivation of YAP1, leading to loss of Hippo tumor-suppressive functions, which ultimately correlated with poor prognosis in a cohort gastric cancer patients (143). The gene discussed is STRN3; the disease is gastric cancer.